Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14390627 | 0.78 | APP (0.48) | ALDH1A1TSHRACHETDP1MAPT | |
| SCHEMBL19371166 | 0.78 | APP (0.48) | ALDH1A1TSHRACHEMAPTALOX15 | |
| SCHEMBL516739 | 0.77 | ALDH1A1 (0.48) | ALDH1A1TSHRACHETDP1MAPT | |
| SCHEMBL3293248 | 0.77 | MEN1 (0.42) | ALDH1A1TSHRTDP1MAPTALOX15 | |
| SCHEMBL516229 | 0.77 | ALDH1A1 (0.48) | ALDH1A1TSHRACHETDP1MAPT | |
| Hydrochloric Acid SCHEMBL27914281 | 0.75 | MEN1 (0.41) | ALDH1A1TSHRTDP1MAPTALOX15 | |
| SCHEMBL2091673 | 0.75 | ALDH1A1 (0.52) | ALDH1A1TSHRACHETDP1MAPT | |
| SCHEMBL11824897 | 0.75 | ALDH1A1 (0.52) | ALDH1A1TSHRACHETDP1MAPT | |
| SCHEMBL7541402 | 0.73 | TDP1 (0.47) | ALDH1A1ACHETDP1MAPTCYP2C19 | |
| SCHEMBL14281278 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRACHETDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1223161-A2 | Method to stabilise and/or lower the color number of alkenyl compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-17 | — | — | EP | disclosed |
| US-20020091254-A1 | Stabilizing and/or lowering the color number of alkenyl compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-11 | — | — | US | disclosed |
| US-6384216-B1 | CARRYING OUT TWO DISTILLATIONS IN WHICH THE PURIFIED ALKENYL COMPOUNDS OBTAINED FROM GAS PHASE BY CONDENSATION, WHERE THE TIME BETWEEN FIRST DISTILLATION AFTER SYNTHESIS OF ALKENYL COMPOUNDS AND FURTHER DISTILLATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | disclosed |
| US-20020038059-A1 | PURIFICATION OF ALKENYL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091254-A1 | Stabilizing and/or lowering the color number of alkenyl compounds | SOD1, NOX4, CAT | ALDH1A1 462/4885TSHR 4454/4885ACHE 1814/4885 |
| US-20020038059-A1 | PURIFICATION OF ALKENYL COMPOUNDS | TPR, AGPAT5, PCNA | ALDH1A1 1108/4885TSHR 3704/4885ACHE 1407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.